Zoledronic Acid and Renal Toxicity: Data from French Adverse Effect Reporting Database
Annals of Pharmacotherapy2005Vol. 39(7-8), pp. 1194–1197
Citations Over TimeTop 10% of 2005 papers
Aline Munier, Valérie Gras, Michel Andréjak, Nathalie Bernard, M.-J. Jean-Pastor, Sophie Gautier, M Biour, Ziad A. Massy
Abstract
These cases emphasize the need for regular monitoring of renal function during zoledronic acid treatment, with particular attention to patients with preexisting impaired renal function.
Related Papers
- → Is zoledronic acid an anticancer drug?(2009)1 cited
- Anti-cancer activity of zoledronic acid in breast cancer(2009)
- Clinical study on zoledronic acid in treatment of pain caused by metastatic bone tumors(2007)
- To observe clinical efficiency of zoledronic acid for the treatment of multiple myeloma(MM) with oslalgia(2008)
- Clinical research on zoledronic acid in treatment of pain caused by bone metastasis of malignant tumors(2007)